| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/11/1998 | CA2276666A1 13-thia prostaglandins for use in glaucoma therapy |
| 09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862564A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 09/09/1998 | EP0862456A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 09/09/1998 | EP0862450A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 09/09/1998 | EP0862435A1 Inhibitors of farnesyl-protein transferase |
| 09/09/1998 | EP0862431A1 Pharmaceutical formulation |
| 09/09/1998 | EP0862414A1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1192687A Bacterial inhibition with an oligosaccharide compound |
| 09/08/1998 | US5804597 Agent for the prevention or treatment of cataracts |
| 09/08/1998 | US5804593 For treatment of connective tissue degradation, osteo-, rheumatoid-, and septic arthritis; osteopenias, osteoporosis, corneal ulceration, peridontal disease, gastric ulcers. |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/03/1998 | WO1998038186A1 Quinoxalinediones |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998037903A1 Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
| 09/03/1998 | WO1998037896A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | WO1998037764A1 Nucleic acid sequences for atp-binding cassette transporter |
| 09/03/1998 | WO1998026770A3 The topical use of kappa opioid agonists to treat ocular pain |
| 09/03/1998 | CA2282639A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | CA2281887A1 Nucleic acid sequences for atp-binding cassette transporter |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/02/1998 | EP0861659A1 Sustained release drug delivery devices |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861088A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 09/02/1998 | EP0861087A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 09/02/1998 | EP0861079A1 Combination therapy for treating glaucoma |
| 09/02/1998 | EP0766696B1 Thiazolidine derivatives, their preparation and drugs containing same |
| 09/02/1998 | CN1191723A Compound eye drops for preventing and treating eye infection and its preparation |
| 09/01/1998 | US5801199 Pharmaceutical composition for treating acute rhinitis |
| 09/01/1998 | US5801156 Macular degeneration |
| 09/01/1998 | US5800807 Ophthalmic compositions including glycerin and propylene glycol |
| 08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 08/27/1998 | WO1998036747A1 Pharmaceutical composition |
| 08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
| 08/27/1998 | WO1998013031A3 Medicinal aerosol formulations comprising budesonide |
| 08/26/1998 | EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 08/26/1998 | EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification |
| 08/26/1998 | EP0859751A1 Semi-fluorinated alkanes and their use |
| 08/26/1998 | EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 08/26/1998 | EP0859622A1 Extracts of shark cartilage |
| 08/26/1998 | EP0859616A1 Topical composition containing capsazepine |
| 08/26/1998 | EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists |
| 08/26/1998 | CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists |
| 08/26/1998 | CN1191491A 结缔组织生长因子 Connective tissue growth factor |
| 08/25/1998 | US5798378 Treatment of ocular hypertension |
| 08/25/1998 | US5798369 Glaucoma treatment |
| 08/25/1998 | US5798362 Useful as alpha-adrenoreceptor blockers; condensation |
| 08/25/1998 | US5798213 Monoclonal antibodies |
| 08/25/1998 | CA2224111A1 Novel compounds |
| 08/20/1998 | WO1998036098A1 Diagnosis and treatment of glaucoma |
| 08/20/1998 | WO1998035967A2 Biazacyclic crf antagonists |
| 08/20/1998 | WO1998035688A1 Method for destroying retinal pigment epithelial cells |
| 08/20/1998 | DE19712659C1 Use of Alchemilla vulgaris extract as angiogenesis inhibitor |
| 08/20/1998 | CA2281690A1 Method for destroying retinal pigment epithelial cells |
| 08/20/1998 | CA2281525A1 Biazacyclic crf antagonists |
| 08/20/1998 | CA2281000A1 Diagnosis and treatment of glaucoma |
| 08/19/1998 | EP0858442A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 08/19/1998 | EP0858330A1 Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 08/18/1998 | US5795913 Ophthalmic composition |
| 08/18/1998 | US5795886 Anticonvulsants |
| 08/18/1998 | US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae |
| 08/13/1998 | WO1998034942A2 Dinucleotides and their use |
| 08/13/1998 | WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/13/1998 | WO1998034644A1 Compositions and articles for reducing the effects of inflammation |
| 08/13/1998 | WO1998034614A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 08/13/1998 | WO1998034593A1 Method of treating dry eye disease with purinergic receptor agonists |
| 08/13/1998 | WO1998034583A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
| 08/13/1998 | WO1998034485A1 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS |
| 08/13/1998 | CA2280820A1 Method of treating blindness with hnt human neuronal cells |
| 08/13/1998 | CA2280181A1 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
| 08/12/1998 | EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus |
| 08/12/1998 | EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus |
| 08/12/1998 | EP0751947B1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 08/12/1998 | EP0625903B1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 08/12/1998 | CN1190394A Bicyclic-aromatic compound |
| 08/11/1998 | US5792845 Nucleotides encoding angiostatin protein and method of use |
| 08/11/1998 | US5792784 A pseudo-dipeptide product which is histamine or methyl-substituted histamine coupled with a amino acid; used in therapeutical, cosmetological applications and treats vision defect |
| 08/11/1998 | US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 08/11/1998 | CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| 08/07/1998 | CA2222987A1 Novel compounds |
| 08/07/1998 | CA2222978A1 Novel compounds |
| 08/07/1998 | CA2222961A1 Novel compounds |
| 08/06/1998 | WO1998033492A1 Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 08/05/1998 | EP0856050A1 Transforming growth factor alpha hi |
| 08/05/1998 | EP0752990B1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 08/05/1998 | EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/05/1998 | EP0553263B1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
| 08/05/1998 | CN1189829A Piperazino derivatives as neurokinin antagonists |
| 08/05/1998 | CN1189773A Sterile ophthalmological gel prepn. applicable in drops and processfor producing it |
| 08/05/1998 | CN1039416C Process for preparing novel pyrido (3,2-B) (1.5) benzothiazepines |
| 08/04/1998 | US5789435 Topical application of carbonic anhydrase inhibitors |
| 07/30/1998 | WO1998032863A2 Mammalian thioredoxin |
| 07/30/1998 | WO1998032850A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/30/1998 | WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS |